Disposition of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, a new antitumor agent.
D000328:Adult; D000577:Amides / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000652:urine; D001646:Bile / Q000032:analysis; D002247:Carbon Isotopes; D002855:Chromatography, Thin Layer; D003124:Colorimetry; D004285:Dogs; D005243:Feces / Q000032:analysis; D006801:Humans; D007093:Imidazoles / Q000378:metabolism*; D007420:Intestine, Large / Q000032:analysis; D007421:Intestine, Small / Q000032:analysis; D007668:Kidney / Q000032:analysis; D008099:Liver / Q000032:analysis; D008297:Male; D051379:Mice; D011877:Radionuclide Imaging; D013057:Spectrum Analysis; D013270:Stomach / Q000032:analysis; D013997:Time Factors; D014226:Triazenes / Q000378:metabolism; D014466:Ultraviolet Rays
D000577:Amides; D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D007093:Imidazoles; D014226:Triazenes